I-BET762 treatment of samples derived from patients with NMC resulted in terminal differentiation and proliferation arrest of malignant cells [77] and significantly reduced MYC expression in both prostate cancer cells and a patient-derived tumor model associated with growth retardation and reduction of tumor burden [78]. Here, MYC is linked to neoplasm.